Public, Private Investments Must Be Made To Ensure Vaccine Coverage, R&D Into New Immunizations, Takeda Executive Says
Devex: Q&A: Rajeev Venkayya on why vaccines are a worthy investment
“…The success of vaccines going forward, [Rajeev Venkayya, the president of the Global Vaccine Business Unit at Takeda Pharmaceuticals,] says, requires public and policy support for investments ‘to make sure that we’re driving strong immunization coverage everywhere but also investing in new vaccines for the diseases that should be vaccine preventable,’ he said. … Devex sat down with Venkayya in Geneva at a summit held last month during the World Health Assembly…” (Saldinger, 6/28).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.